Walgreens announces a $10 billion deal with Sycamore Partners to take the drugstore chain private

Key Points

  • Walgreens Boots Alliance (WBA) has finalized a $10 billion deal with Sycamore Partners to go private, with potential value up to $23.7 billion.
  • The deal includes all elements of Walgreens, including VillageMD, Alliance Boots, and its pharmacy benefit manager (PBM).
  • Walgreens CEO Tim Wentworth stated the move to private ownership will help manage the company's turnaround strategy more effectively.
  • The stock price of Walgreens surged over 5% in after-hours trading following the announcement.
  • The transaction marks the end of Walgreens' nearly 100-year presence in the public market.

Summary

Walgreens Boots Alliance (WBA) has agreed to a $10 billion deal with Sycamore Partners, a New York-based private equity firm, to go private. This deal, potentially worth up to $23.7 billion, includes all aspects of Walgreens' operations, from its retail pharmacy business to its stake in VillageMD and its specialty pharmacy unit. The agreement comes after four months of negotiations and aims to streamline operations and manage a turnaround strategy more effectively under private ownership. CEO Tim Wentworth highlighted the company's role in the retail healthcare ecosystem and the need for a focused approach to navigate the evolving pharmacy industry. The deal also encompasses the Alliance Boots business, acquired in 2014, and Walgreens' PBM, which has struggled to compete with larger players like UnitedHealth's Optum RX, CVS's Caremark, and Cigna's Express Scripts. Following the announcement, Walgreens' stock saw a significant after-hours increase, reflecting investor optimism about the strategic shift. This move to private ownership ends Walgreens' nearly century-long run as a publicly traded company, reflecting broader trends in the retail pharmacy sector facing pressures from online competition and reimbursement issues.

yahoo
March 7, 2025
Stocks
Read article

Related news